CN112410355A - Acyl-coenzyme A oxidase 2 gene RKACOX2 and application thereof - Google Patents
Acyl-coenzyme A oxidase 2 gene RKACOX2 and application thereof Download PDFInfo
- Publication number
- CN112410355A CN112410355A CN202011322537.1A CN202011322537A CN112410355A CN 112410355 A CN112410355 A CN 112410355A CN 202011322537 A CN202011322537 A CN 202011322537A CN 112410355 A CN112410355 A CN 112410355A
- Authority
- CN
- China
- Prior art keywords
- gene
- ala
- rkacox2
- leu
- carotenoid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101710103615 Acyl-coenzyme A oxidase 2 Proteins 0.000 title claims abstract description 15
- 235000021466 carotenoid Nutrition 0.000 claims abstract description 51
- 150000001747 carotenoids Chemical class 0.000 claims abstract description 51
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 41
- 238000004519 manufacturing process Methods 0.000 claims abstract description 13
- 239000002773 nucleotide Substances 0.000 claims abstract description 7
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 7
- 230000000813 microbial effect Effects 0.000 claims abstract description 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 102100026795 Peroxisomal acyl-coenzyme A oxidase 2 Human genes 0.000 claims description 9
- 230000001737 promoting effect Effects 0.000 claims 1
- 241000221523 Rhodotorula toruloides Species 0.000 abstract description 24
- 238000003786 synthesis reaction Methods 0.000 abstract description 20
- 230000015572 biosynthetic process Effects 0.000 abstract description 17
- 238000013518 transcription Methods 0.000 abstract description 11
- 230000035897 transcription Effects 0.000 abstract description 11
- 241000007100 Rhodotorula kratochvilovae Species 0.000 abstract description 10
- 230000002018 overexpression Effects 0.000 abstract description 10
- 244000005700 microbiome Species 0.000 abstract description 3
- 238000000034 method Methods 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 10
- 239000013598 vector Substances 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 239000013604 expression vector Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000009261 transgenic effect Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108010005233 alanylglutamic acid Proteins 0.000 description 3
- 108010070944 alanylhistidine Proteins 0.000 description 3
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 3
- 108010057821 leucylproline Proteins 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 3
- LGFCAXJBAZESCF-ACZMJKKPSA-N Ala-Gln-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O LGFCAXJBAZESCF-ACZMJKKPSA-N 0.000 description 2
- XYOVHPDDWCEUDY-CIUDSAMLSA-N Asn-Ala-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O XYOVHPDDWCEUDY-CIUDSAMLSA-N 0.000 description 2
- KRXIWXCXOARFNT-ZLUOBGJFSA-N Asp-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O KRXIWXCXOARFNT-ZLUOBGJFSA-N 0.000 description 2
- HRQKOYFGHJYEFS-UHFFFAOYSA-N Beta psi-carotene Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C HRQKOYFGHJYEFS-UHFFFAOYSA-N 0.000 description 2
- 108091092584 GDNA Proteins 0.000 description 2
- IRXNJYPKBVERCW-DCAQKATOSA-N Glu-Leu-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IRXNJYPKBVERCW-DCAQKATOSA-N 0.000 description 2
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 2
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 238000010806 PrimeScriptTM RT Reagent kit Methods 0.000 description 2
- 238000010802 RNA extraction kit Methods 0.000 description 2
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 2
- DIOSYUIWOQCXNR-ONGXEEELSA-N Val-Lys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O DIOSYUIWOQCXNR-ONGXEEELSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000011663 gamma-carotene Substances 0.000 description 2
- 235000000633 gamma-carotene Nutrition 0.000 description 2
- HRQKOYFGHJYEFS-RZWPOVEWSA-N gamma-carotene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=1C(C)(C)CCCC=1C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C HRQKOYFGHJYEFS-RZWPOVEWSA-N 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 108010078144 glutaminyl-glycine Proteins 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Chemical compound NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 2
- 229940097277 hygromycin b Drugs 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108010004914 prolylarginine Proteins 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- NESPPCWGYRQEJQ-VATUXEBJSA-N (2e,4e,6e,8e,10e,12e,14e,16e,18e,20e,22e,24e)-2,6,10,14,19,23-hexamethyl-25-(2,6,6-trimethylcyclohexen-1-yl)pentacosa-2,4,6,8,10,12,14,16,18,20,22,24-dodecaenoic acid Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C NESPPCWGYRQEJQ-VATUXEBJSA-N 0.000 description 1
- XVZCXCTYGHPNEM-IHRRRGAJSA-N (2s)-1-[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O XVZCXCTYGHPNEM-IHRRRGAJSA-N 0.000 description 1
- NTWUFSCNXWKSGG-BOLZHIRLSA-N (2s)-2-[[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-n-[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]-3-methylpentanamide Chemical compound C([C@H](N)C(=O)NCC(=O)N[C@@H](C(C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)C1=CC=C(O)C=C1 NTWUFSCNXWKSGG-BOLZHIRLSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- 108020004565 5.8S Ribosomal RNA Proteins 0.000 description 1
- FJVAQLJNTSUQPY-CIUDSAMLSA-N Ala-Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN FJVAQLJNTSUQPY-CIUDSAMLSA-N 0.000 description 1
- XCVRVWZTXPCYJT-BIIVOSGPSA-N Ala-Asn-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N XCVRVWZTXPCYJT-BIIVOSGPSA-N 0.000 description 1
- NHCPCLJZRSIDHS-ZLUOBGJFSA-N Ala-Asp-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O NHCPCLJZRSIDHS-ZLUOBGJFSA-N 0.000 description 1
- GSCLWXDNIMNIJE-ZLUOBGJFSA-N Ala-Asp-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O GSCLWXDNIMNIJE-ZLUOBGJFSA-N 0.000 description 1
- WXERCAHAIKMTKX-ZLUOBGJFSA-N Ala-Asp-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O WXERCAHAIKMTKX-ZLUOBGJFSA-N 0.000 description 1
- MCKSLROAGSDNFC-ACZMJKKPSA-N Ala-Asp-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MCKSLROAGSDNFC-ACZMJKKPSA-N 0.000 description 1
- WDIYWDJLXOCGRW-ACZMJKKPSA-N Ala-Asp-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WDIYWDJLXOCGRW-ACZMJKKPSA-N 0.000 description 1
- CZPAHAKGPDUIPJ-CIUDSAMLSA-N Ala-Gln-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O CZPAHAKGPDUIPJ-CIUDSAMLSA-N 0.000 description 1
- NWVVKQZOVSTDBQ-CIUDSAMLSA-N Ala-Glu-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NWVVKQZOVSTDBQ-CIUDSAMLSA-N 0.000 description 1
- NIZKGBJVCMRDKO-KWQFWETISA-N Ala-Gly-Tyr Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NIZKGBJVCMRDKO-KWQFWETISA-N 0.000 description 1
- CKLDHDOIYBVUNP-KBIXCLLPSA-N Ala-Ile-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O CKLDHDOIYBVUNP-KBIXCLLPSA-N 0.000 description 1
- YHKANGMVQWRMAP-DCAQKATOSA-N Ala-Leu-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YHKANGMVQWRMAP-DCAQKATOSA-N 0.000 description 1
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 description 1
- MFMDKJIPHSWSBM-GUBZILKMSA-N Ala-Lys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFMDKJIPHSWSBM-GUBZILKMSA-N 0.000 description 1
- PMQXMXAASGFUDX-SRVKXCTJSA-N Ala-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCCN PMQXMXAASGFUDX-SRVKXCTJSA-N 0.000 description 1
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 1
- MDNAVFBZPROEHO-UHFFFAOYSA-N Ala-Lys-Val Natural products CC(C)C(C(O)=O)NC(=O)C(NC(=O)C(C)N)CCCCN MDNAVFBZPROEHO-UHFFFAOYSA-N 0.000 description 1
- OMDNCNKNEGFOMM-BQBZGAKWSA-N Ala-Met-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O OMDNCNKNEGFOMM-BQBZGAKWSA-N 0.000 description 1
- GFEDXKNBZMPEDM-KZVJFYERSA-N Ala-Met-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GFEDXKNBZMPEDM-KZVJFYERSA-N 0.000 description 1
- DRARURMRLANNLS-GUBZILKMSA-N Ala-Met-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O DRARURMRLANNLS-GUBZILKMSA-N 0.000 description 1
- BDQNLQSWRAPHGU-DLOVCJGASA-N Ala-Phe-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CS)C(=O)O)N BDQNLQSWRAPHGU-DLOVCJGASA-N 0.000 description 1
- MAZZQZWCCYJQGZ-GUBZILKMSA-N Ala-Pro-Arg Chemical compound [H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MAZZQZWCCYJQGZ-GUBZILKMSA-N 0.000 description 1
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 1
- IOFVWPYSRSCWHI-JXUBOQSCSA-N Ala-Thr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)N IOFVWPYSRSCWHI-JXUBOQSCSA-N 0.000 description 1
- SAHQGRZIQVEJPF-JXUBOQSCSA-N Ala-Thr-Lys Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN SAHQGRZIQVEJPF-JXUBOQSCSA-N 0.000 description 1
- FSXDWQGEWZQBPJ-HERUPUMHSA-N Ala-Trp-Asp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)O)C(=O)O)N FSXDWQGEWZQBPJ-HERUPUMHSA-N 0.000 description 1
- ZJLORAAXDAJLDC-CQDKDKBSSA-N Ala-Tyr-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O ZJLORAAXDAJLDC-CQDKDKBSSA-N 0.000 description 1
- IYKVSFNGSWTTNZ-GUBZILKMSA-N Ala-Val-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IYKVSFNGSWTTNZ-GUBZILKMSA-N 0.000 description 1
- DHONNEYAZPNGSG-UBHSHLNASA-N Ala-Val-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 DHONNEYAZPNGSG-UBHSHLNASA-N 0.000 description 1
- KGSJCPBERYUXCN-BPNCWPANSA-N Arg-Ala-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KGSJCPBERYUXCN-BPNCWPANSA-N 0.000 description 1
- NKNILFJYKKHBKE-WPRPVWTQSA-N Arg-Gly-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O NKNILFJYKKHBKE-WPRPVWTQSA-N 0.000 description 1
- GNYUVVJYGJFKHN-RVMXOQNASA-N Arg-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N GNYUVVJYGJFKHN-RVMXOQNASA-N 0.000 description 1
- DNUKXVMPARLPFN-XUXIUFHCSA-N Arg-Leu-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DNUKXVMPARLPFN-XUXIUFHCSA-N 0.000 description 1
- XUGATJVGQUGQKY-ULQDDVLXSA-N Arg-Lys-Phe Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XUGATJVGQUGQKY-ULQDDVLXSA-N 0.000 description 1
- PSOPJDUQUVFSLS-GUBZILKMSA-N Arg-Met-Cys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N PSOPJDUQUVFSLS-GUBZILKMSA-N 0.000 description 1
- NIELFHOLFTUZME-HJWJTTGWSA-N Arg-Phe-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NIELFHOLFTUZME-HJWJTTGWSA-N 0.000 description 1
- YCYXHLZRUSJITQ-SRVKXCTJSA-N Arg-Pro-Pro Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 YCYXHLZRUSJITQ-SRVKXCTJSA-N 0.000 description 1
- KMFPQTITXUKJOV-DCAQKATOSA-N Arg-Ser-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O KMFPQTITXUKJOV-DCAQKATOSA-N 0.000 description 1
- JKRPBTQDPJSQIT-RCWTZXSCSA-N Arg-Thr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O JKRPBTQDPJSQIT-RCWTZXSCSA-N 0.000 description 1
- AOJYORNRFWWEIV-IHRRRGAJSA-N Arg-Tyr-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CC=C(O)C=C1 AOJYORNRFWWEIV-IHRRRGAJSA-N 0.000 description 1
- ORXCYAFUCSTQGY-FXQIFTODSA-N Asn-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N)N ORXCYAFUCSTQGY-FXQIFTODSA-N 0.000 description 1
- WQLJRNRLHWJIRW-KKUMJFAQSA-N Asn-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)N)N)O WQLJRNRLHWJIRW-KKUMJFAQSA-N 0.000 description 1
- AWXDRZJQCVHCIT-DCAQKATOSA-N Asn-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O AWXDRZJQCVHCIT-DCAQKATOSA-N 0.000 description 1
- HCZQKHSRYHCPSD-IUKAMOBKSA-N Asn-Thr-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HCZQKHSRYHCPSD-IUKAMOBKSA-N 0.000 description 1
- WQAOZCVOOYUWKG-LSJOCFKGSA-N Asn-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CC(=O)N)N WQAOZCVOOYUWKG-LSJOCFKGSA-N 0.000 description 1
- GWTLRDMPMJCNMH-WHFBIAKZSA-N Asp-Asn-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GWTLRDMPMJCNMH-WHFBIAKZSA-N 0.000 description 1
- VAWNQIGQPUOPQW-ACZMJKKPSA-N Asp-Glu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VAWNQIGQPUOPQW-ACZMJKKPSA-N 0.000 description 1
- PSLSTUMPZILTAH-BYULHYEWSA-N Asp-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O PSLSTUMPZILTAH-BYULHYEWSA-N 0.000 description 1
- TVIZQBFURPLQDV-DJFWLOJKSA-N Asp-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(=O)O)N TVIZQBFURPLQDV-DJFWLOJKSA-N 0.000 description 1
- MFTVXYMXSAQZNL-DJFWLOJKSA-N Asp-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(=O)O)N MFTVXYMXSAQZNL-DJFWLOJKSA-N 0.000 description 1
- RTXQQDVBACBSCW-CFMVVWHZSA-N Asp-Ile-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RTXQQDVBACBSCW-CFMVVWHZSA-N 0.000 description 1
- UMHUHHJMEXNSIV-CIUDSAMLSA-N Asp-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UMHUHHJMEXNSIV-CIUDSAMLSA-N 0.000 description 1
- ORRJQLIATJDMQM-HJGDQZAQSA-N Asp-Leu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O ORRJQLIATJDMQM-HJGDQZAQSA-N 0.000 description 1
- DONWIPDSZZJHHK-HJGDQZAQSA-N Asp-Lys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)N)O DONWIPDSZZJHHK-HJGDQZAQSA-N 0.000 description 1
- YFGUZQQCSDZRBN-DCAQKATOSA-N Asp-Pro-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O YFGUZQQCSDZRBN-DCAQKATOSA-N 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- PMTBZAVERRPRHU-YGVNLFKFSA-N CC1(C)CCCC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C.CC1(C)CCCC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C Chemical compound CC1(C)CCCC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C.CC1(C)CCCC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C PMTBZAVERRPRHU-YGVNLFKFSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- SZQCDCKIGWQAQN-FXQIFTODSA-N Cys-Arg-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O SZQCDCKIGWQAQN-FXQIFTODSA-N 0.000 description 1
- SAEVTQWAYDPXMU-KATARQTJSA-N Cys-Thr-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O SAEVTQWAYDPXMU-KATARQTJSA-N 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004593 Epoxy Chemical class 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- JSYULGSPLTZDHM-NRPADANISA-N Gln-Ala-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O JSYULGSPLTZDHM-NRPADANISA-N 0.000 description 1
- COYGBRTZEVWZBW-XKBZYTNZSA-N Gln-Cys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(N)=O COYGBRTZEVWZBW-XKBZYTNZSA-N 0.000 description 1
- LKVCNGLNTAPMSZ-JYJNAYRXSA-N Gln-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCC(=O)N)N LKVCNGLNTAPMSZ-JYJNAYRXSA-N 0.000 description 1
- MLSKFHLRFVGNLL-WDCWCFNPSA-N Gln-Leu-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MLSKFHLRFVGNLL-WDCWCFNPSA-N 0.000 description 1
- JUUNNOLZGVYCJT-JYJNAYRXSA-N Gln-Phe-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N)N JUUNNOLZGVYCJT-JYJNAYRXSA-N 0.000 description 1
- OSCLNNWLKKIQJM-WDSKDSINSA-N Gln-Ser-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O OSCLNNWLKKIQJM-WDSKDSINSA-N 0.000 description 1
- AKJRHDMTEJXTPV-ACZMJKKPSA-N Glu-Asn-Ala Chemical compound C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O AKJRHDMTEJXTPV-ACZMJKKPSA-N 0.000 description 1
- UMIRPYLZFKOEOH-YVNDNENWSA-N Glu-Gln-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UMIRPYLZFKOEOH-YVNDNENWSA-N 0.000 description 1
- CGOHAEBMDSEKFB-FXQIFTODSA-N Glu-Glu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O CGOHAEBMDSEKFB-FXQIFTODSA-N 0.000 description 1
- BUZMZDDKFCSKOT-CIUDSAMLSA-N Glu-Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 1
- QJCKNLPMTPXXEM-AUTRQRHGSA-N Glu-Glu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O QJCKNLPMTPXXEM-AUTRQRHGSA-N 0.000 description 1
- AIGROOHQXCACHL-WDSKDSINSA-N Glu-Gly-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(O)=O AIGROOHQXCACHL-WDSKDSINSA-N 0.000 description 1
- MTAOBYXRYJZRGQ-WDSKDSINSA-N Glu-Gly-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MTAOBYXRYJZRGQ-WDSKDSINSA-N 0.000 description 1
- OGNJZUXUTPQVBR-BQBZGAKWSA-N Glu-Gly-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OGNJZUXUTPQVBR-BQBZGAKWSA-N 0.000 description 1
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 1
- DNPCBMNFQVTHMA-DCAQKATOSA-N Glu-Leu-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O DNPCBMNFQVTHMA-DCAQKATOSA-N 0.000 description 1
- BCYGDJXHAGZNPQ-DCAQKATOSA-N Glu-Lys-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O BCYGDJXHAGZNPQ-DCAQKATOSA-N 0.000 description 1
- DDXZHOHEABQXSE-NKIYYHGXSA-N Glu-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O DDXZHOHEABQXSE-NKIYYHGXSA-N 0.000 description 1
- UCZXXMREFIETQW-AVGNSLFASA-N Glu-Tyr-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O UCZXXMREFIETQW-AVGNSLFASA-N 0.000 description 1
- WGYHAAXZWPEBDQ-IFFSRLJSSA-N Glu-Val-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGYHAAXZWPEBDQ-IFFSRLJSSA-N 0.000 description 1
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 1
- QSDKBRMVXSWAQE-BFHQHQDPSA-N Gly-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN QSDKBRMVXSWAQE-BFHQHQDPSA-N 0.000 description 1
- DTPOVRRYXPJJAZ-FJXKBIBVSA-N Gly-Arg-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N DTPOVRRYXPJJAZ-FJXKBIBVSA-N 0.000 description 1
- XBWMTPAIUQIWKA-BYULHYEWSA-N Gly-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN XBWMTPAIUQIWKA-BYULHYEWSA-N 0.000 description 1
- SABZDFAAOJATBR-QWRGUYRKSA-N Gly-Cys-Phe Chemical compound [H]NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SABZDFAAOJATBR-QWRGUYRKSA-N 0.000 description 1
- GHHAMXVMWXMGSV-STQMWFEESA-N Gly-Cys-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CS)NC(=O)CN)C(O)=O)=CNC2=C1 GHHAMXVMWXMGSV-STQMWFEESA-N 0.000 description 1
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 1
- ADZGCWWDPFDHCY-ZETCQYMHSA-N Gly-His-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 ADZGCWWDPFDHCY-ZETCQYMHSA-N 0.000 description 1
- SWQALSGKVLYKDT-ZKWXMUAHSA-N Gly-Ile-Ala Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SWQALSGKVLYKDT-ZKWXMUAHSA-N 0.000 description 1
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 1
- LLZXNUUIBOALNY-QWRGUYRKSA-N Gly-Leu-Lys Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN LLZXNUUIBOALNY-QWRGUYRKSA-N 0.000 description 1
- VEPBEGNDJYANCF-QWRGUYRKSA-N Gly-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCCN VEPBEGNDJYANCF-QWRGUYRKSA-N 0.000 description 1
- FJWSJWACLMTDMI-WPRPVWTQSA-N Gly-Met-Val Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O FJWSJWACLMTDMI-WPRPVWTQSA-N 0.000 description 1
- IALQAMYQJBZNSK-WHFBIAKZSA-N Gly-Ser-Asn Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O IALQAMYQJBZNSK-WHFBIAKZSA-N 0.000 description 1
- XHVONGZZVUUORG-WEDXCCLWSA-N Gly-Thr-Lys Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN XHVONGZZVUUORG-WEDXCCLWSA-N 0.000 description 1
- FULZDMOZUZKGQU-ONGXEEELSA-N Gly-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN FULZDMOZUZKGQU-ONGXEEELSA-N 0.000 description 1
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 1
- BDHUXUFYNUOUIT-SRVKXCTJSA-N His-Asp-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N BDHUXUFYNUOUIT-SRVKXCTJSA-N 0.000 description 1
- KAXZXLSXFWSNNZ-XVYDVKMFSA-N His-Ser-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KAXZXLSXFWSNNZ-XVYDVKMFSA-N 0.000 description 1
- JUCZDDVZBMPKRT-IXOXFDKPSA-N His-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N)O JUCZDDVZBMPKRT-IXOXFDKPSA-N 0.000 description 1
- UPJODPVSKKWGDQ-KLHWPWHYSA-N His-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)O UPJODPVSKKWGDQ-KLHWPWHYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- FVEWRQXNISSYFO-ZPFDUUQYSA-N Ile-Arg-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N FVEWRQXNISSYFO-ZPFDUUQYSA-N 0.000 description 1
- HDODQNPMSHDXJT-GHCJXIJMSA-N Ile-Asn-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O HDODQNPMSHDXJT-GHCJXIJMSA-N 0.000 description 1
- BALLIXFZYSECCF-QEWYBTABSA-N Ile-Gln-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N BALLIXFZYSECCF-QEWYBTABSA-N 0.000 description 1
- DFJJAVZIHDFOGQ-MNXVOIDGSA-N Ile-Glu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N DFJJAVZIHDFOGQ-MNXVOIDGSA-N 0.000 description 1
- CNMOKANDJMLAIF-CIQUZCHMSA-N Ile-Thr-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O CNMOKANDJMLAIF-CIQUZCHMSA-N 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical group CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- UCOCBWDBHCUPQP-DCAQKATOSA-N Leu-Arg-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O UCOCBWDBHCUPQP-DCAQKATOSA-N 0.000 description 1
- CLVUXCBGKUECIT-HJGDQZAQSA-N Leu-Asp-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CLVUXCBGKUECIT-HJGDQZAQSA-N 0.000 description 1
- VQPPIMUZCZCOIL-GUBZILKMSA-N Leu-Gln-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O VQPPIMUZCZCOIL-GUBZILKMSA-N 0.000 description 1
- RVVBWTWPNFDYBE-SRVKXCTJSA-N Leu-Glu-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVVBWTWPNFDYBE-SRVKXCTJSA-N 0.000 description 1
- HQUXQAMSWFIRET-AVGNSLFASA-N Leu-Glu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN HQUXQAMSWFIRET-AVGNSLFASA-N 0.000 description 1
- PRZVBIAOPFGAQF-SRVKXCTJSA-N Leu-Glu-Met Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O PRZVBIAOPFGAQF-SRVKXCTJSA-N 0.000 description 1
- ZFNLIDNJUWNIJL-WDCWCFNPSA-N Leu-Glu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZFNLIDNJUWNIJL-WDCWCFNPSA-N 0.000 description 1
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 1
- JNDYEOUZBLOVOF-AVGNSLFASA-N Leu-Leu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JNDYEOUZBLOVOF-AVGNSLFASA-N 0.000 description 1
- VCHVSKNMTXWIIP-SRVKXCTJSA-N Leu-Lys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O VCHVSKNMTXWIIP-SRVKXCTJSA-N 0.000 description 1
- ONPJGOIVICHWBW-BZSNNMDCSA-N Leu-Lys-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 ONPJGOIVICHWBW-BZSNNMDCSA-N 0.000 description 1
- LJBVRCDPWOJOEK-PPCPHDFISA-N Leu-Thr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LJBVRCDPWOJOEK-PPCPHDFISA-N 0.000 description 1
- QWWPYKKLXWOITQ-VOAKCMCISA-N Leu-Thr-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QWWPYKKLXWOITQ-VOAKCMCISA-N 0.000 description 1
- GZRABTMNWJXFMH-UVOCVTCTSA-N Leu-Thr-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZRABTMNWJXFMH-UVOCVTCTSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- PNPYKQFJGRFYJE-GUBZILKMSA-N Lys-Ala-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNPYKQFJGRFYJE-GUBZILKMSA-N 0.000 description 1
- DFXQCCBKGUNYGG-GUBZILKMSA-N Lys-Gln-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN DFXQCCBKGUNYGG-GUBZILKMSA-N 0.000 description 1
- GQZMPWBZQALKJO-UWVGGRQHSA-N Lys-Gly-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O GQZMPWBZQALKJO-UWVGGRQHSA-N 0.000 description 1
- RBEATVHTWHTHTJ-KKUMJFAQSA-N Lys-Leu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O RBEATVHTWHTHTJ-KKUMJFAQSA-N 0.000 description 1
- XOQMURBBIXRRCR-SRVKXCTJSA-N Lys-Lys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN XOQMURBBIXRRCR-SRVKXCTJSA-N 0.000 description 1
- UZVWDRPUTHXQAM-FXQIFTODSA-N Met-Asp-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O UZVWDRPUTHXQAM-FXQIFTODSA-N 0.000 description 1
- PNDCUTDWYVKBHX-IHRRRGAJSA-N Met-Asp-Tyr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PNDCUTDWYVKBHX-IHRRRGAJSA-N 0.000 description 1
- FYRUJIJAUPHUNB-IUCAKERBSA-N Met-Gly-Arg Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N FYRUJIJAUPHUNB-IUCAKERBSA-N 0.000 description 1
- LBNFTWKGISQVEE-AVGNSLFASA-N Met-Leu-Met Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCSC LBNFTWKGISQVEE-AVGNSLFASA-N 0.000 description 1
- FBLBCGLSRXBANI-KKUMJFAQSA-N Met-Phe-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N FBLBCGLSRXBANI-KKUMJFAQSA-N 0.000 description 1
- LUYURUYVNYGKGM-RCWTZXSCSA-N Met-Pro-Thr Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O LUYURUYVNYGKGM-RCWTZXSCSA-N 0.000 description 1
- RMLLCGYYVZKKRT-CIUDSAMLSA-N Met-Ser-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O RMLLCGYYVZKKRT-CIUDSAMLSA-N 0.000 description 1
- SOAYQFDWEIWPPR-IHRRRGAJSA-N Met-Ser-Tyr Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O SOAYQFDWEIWPPR-IHRRRGAJSA-N 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- PESQCPHRXOFIPX-UHFFFAOYSA-N N-L-methionyl-L-tyrosine Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-UHFFFAOYSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- 108010087066 N2-tryptophyllysine Proteins 0.000 description 1
- 108010065395 Neuropep-1 Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- YRKFKTQRVBJYLT-CQDKDKBSSA-N Phe-Ala-His Chemical compound C([C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=CC=C1 YRKFKTQRVBJYLT-CQDKDKBSSA-N 0.000 description 1
- PLNHHOXNVSYKOB-JYJNAYRXSA-N Phe-Arg-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CC=CC=C1)N PLNHHOXNVSYKOB-JYJNAYRXSA-N 0.000 description 1
- DDYIRGBOZVKRFR-AVGNSLFASA-N Phe-Asp-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DDYIRGBOZVKRFR-AVGNSLFASA-N 0.000 description 1
- RIYZXJVARWJLKS-KKUMJFAQSA-N Phe-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 RIYZXJVARWJLKS-KKUMJFAQSA-N 0.000 description 1
- KYYMILWEGJYPQZ-IHRRRGAJSA-N Phe-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 KYYMILWEGJYPQZ-IHRRRGAJSA-N 0.000 description 1
- FIRWJEJVFFGXSH-RYUDHWBXSA-N Phe-Glu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 FIRWJEJVFFGXSH-RYUDHWBXSA-N 0.000 description 1
- DOXQMJCSSYZSNM-BZSNNMDCSA-N Phe-Lys-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O DOXQMJCSSYZSNM-BZSNNMDCSA-N 0.000 description 1
- MGLBSROLWAWCKN-FCLVOEFKSA-N Phe-Phe-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MGLBSROLWAWCKN-FCLVOEFKSA-N 0.000 description 1
- GNRMAQSIROFNMI-IXOXFDKPSA-N Phe-Thr-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O GNRMAQSIROFNMI-IXOXFDKPSA-N 0.000 description 1
- BQMFWUKNOCJDNV-HJWJTTGWSA-N Phe-Val-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BQMFWUKNOCJDNV-HJWJTTGWSA-N 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- INXAPZFIOVGHSV-CIUDSAMLSA-N Pro-Asn-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1 INXAPZFIOVGHSV-CIUDSAMLSA-N 0.000 description 1
- HAAQQNHQZBOWFO-LURJTMIESA-N Pro-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1 HAAQQNHQZBOWFO-LURJTMIESA-N 0.000 description 1
- YXHYJEPDKSYPSQ-AVGNSLFASA-N Pro-Leu-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 YXHYJEPDKSYPSQ-AVGNSLFASA-N 0.000 description 1
- FXGIMYRVJJEIIM-UWVGGRQHSA-N Pro-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FXGIMYRVJJEIIM-UWVGGRQHSA-N 0.000 description 1
- CGSOWZUPLOKYOR-AVGNSLFASA-N Pro-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 CGSOWZUPLOKYOR-AVGNSLFASA-N 0.000 description 1
- SEZGGSHLMROBFX-CIUDSAMLSA-N Pro-Ser-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O SEZGGSHLMROBFX-CIUDSAMLSA-N 0.000 description 1
- BJCXXMGGPHRSHV-GUBZILKMSA-N Pro-Ser-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 BJCXXMGGPHRSHV-GUBZILKMSA-N 0.000 description 1
- PRKWBYCXBBSLSK-GUBZILKMSA-N Pro-Ser-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O PRKWBYCXBBSLSK-GUBZILKMSA-N 0.000 description 1
- OOZJHTXCLJUODH-QXEWZRGKSA-N Pro-Val-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 OOZJHTXCLJUODH-QXEWZRGKSA-N 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000223254 Rhodotorula mucilaginosa Species 0.000 description 1
- HRNQLKCLPVKZNE-CIUDSAMLSA-N Ser-Ala-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O HRNQLKCLPVKZNE-CIUDSAMLSA-N 0.000 description 1
- MMAPOBOTRUVNKJ-ZLUOBGJFSA-N Ser-Asp-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CO)N)C(=O)O MMAPOBOTRUVNKJ-ZLUOBGJFSA-N 0.000 description 1
- RFBKULCUBJAQFT-BIIVOSGPSA-N Ser-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CO)N)C(=O)O RFBKULCUBJAQFT-BIIVOSGPSA-N 0.000 description 1
- ZOHGLPQGEHSLPD-FXQIFTODSA-N Ser-Gln-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZOHGLPQGEHSLPD-FXQIFTODSA-N 0.000 description 1
- OLKICIBQRVSQMA-SRVKXCTJSA-N Ser-Ser-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OLKICIBQRVSQMA-SRVKXCTJSA-N 0.000 description 1
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 1
- JGUWRQWULDWNCM-FXQIFTODSA-N Ser-Val-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O JGUWRQWULDWNCM-FXQIFTODSA-N 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- BSNZTJXVDOINSR-JXUBOQSCSA-N Thr-Ala-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BSNZTJXVDOINSR-JXUBOQSCSA-N 0.000 description 1
- CAJFZCICSVBOJK-SHGPDSBTSA-N Thr-Ala-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAJFZCICSVBOJK-SHGPDSBTSA-N 0.000 description 1
- UNURFMVMXLENAZ-KJEVXHAQSA-N Thr-Arg-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O UNURFMVMXLENAZ-KJEVXHAQSA-N 0.000 description 1
- PZVGOVRNGKEFCB-KKHAAJSZSA-N Thr-Asn-Val Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N)O PZVGOVRNGKEFCB-KKHAAJSZSA-N 0.000 description 1
- NIEWSKWFURSECR-FOHZUACHSA-N Thr-Gly-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O NIEWSKWFURSECR-FOHZUACHSA-N 0.000 description 1
- KRGDDWVBBDLPSJ-CUJWVEQBSA-N Thr-His-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O KRGDDWVBBDLPSJ-CUJWVEQBSA-N 0.000 description 1
- HOVLHEKTGVIKAP-WDCWCFNPSA-N Thr-Leu-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O HOVLHEKTGVIKAP-WDCWCFNPSA-N 0.000 description 1
- VTVVYQOXJCZVEB-WDCWCFNPSA-N Thr-Leu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O VTVVYQOXJCZVEB-WDCWCFNPSA-N 0.000 description 1
- XSEPSRUDSPHMPX-KATARQTJSA-N Thr-Lys-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O XSEPSRUDSPHMPX-KATARQTJSA-N 0.000 description 1
- UJQVSMNQMQHVRY-KZVJFYERSA-N Thr-Met-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O UJQVSMNQMQHVRY-KZVJFYERSA-N 0.000 description 1
- NWECYMJLJGCBOD-UNQGMJICSA-N Thr-Phe-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O NWECYMJLJGCBOD-UNQGMJICSA-N 0.000 description 1
- FWTFAZKJORVTIR-VZFHVOOUSA-N Thr-Ser-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O FWTFAZKJORVTIR-VZFHVOOUSA-N 0.000 description 1
- BJJRNAVDQGREGC-HOUAVDHOSA-N Thr-Trp-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O BJJRNAVDQGREGC-HOUAVDHOSA-N 0.000 description 1
- REJRKTOJTCPDPO-IRIUXVKKSA-N Thr-Tyr-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O REJRKTOJTCPDPO-IRIUXVKKSA-N 0.000 description 1
- 102000006601 Thymidine Kinase Human genes 0.000 description 1
- 108020004440 Thymidine kinase Proteins 0.000 description 1
- NESPPCWGYRQEJQ-AGUCYFRTSA-N Torularhodin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC=C(/C)C=CC=C(/C)C(=O)O NESPPCWGYRQEJQ-AGUCYFRTSA-N 0.000 description 1
- KIMOCKLJBXHFIN-YLVFBTJISA-N Trp-Ile-Gly Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O)=CNC2=C1 KIMOCKLJBXHFIN-YLVFBTJISA-N 0.000 description 1
- HJWLQSFTGDQSRX-BPUTZDHNSA-N Trp-Met-Ser Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(O)=O HJWLQSFTGDQSRX-BPUTZDHNSA-N 0.000 description 1
- OEVJGIHPQOXYFE-SRVKXCTJSA-N Tyr-Asn-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O OEVJGIHPQOXYFE-SRVKXCTJSA-N 0.000 description 1
- CNLKDWSAORJEMW-KWQFWETISA-N Tyr-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O CNLKDWSAORJEMW-KWQFWETISA-N 0.000 description 1
- VYQQQIRHIFALGE-UWJYBYFXSA-N Tyr-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 VYQQQIRHIFALGE-UWJYBYFXSA-N 0.000 description 1
- ASQFIHTXXMFENG-XPUUQOCRSA-N Val-Ala-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O ASQFIHTXXMFENG-XPUUQOCRSA-N 0.000 description 1
- KKHRWGYHBZORMQ-NHCYSSNCSA-N Val-Arg-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KKHRWGYHBZORMQ-NHCYSSNCSA-N 0.000 description 1
- ZIGZPYJXIWLQFC-QTKMDUPCSA-N Val-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](C(C)C)N)O ZIGZPYJXIWLQFC-QTKMDUPCSA-N 0.000 description 1
- LYERIXUFCYVFFX-GVXVVHGQSA-N Val-Leu-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N LYERIXUFCYVFFX-GVXVVHGQSA-N 0.000 description 1
- RWOGENDAOGMHLX-DCAQKATOSA-N Val-Lys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)N RWOGENDAOGMHLX-DCAQKATOSA-N 0.000 description 1
- ZRSZTKTVPNSUNA-IHRRRGAJSA-N Val-Lys-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(O)=O ZRSZTKTVPNSUNA-IHRRRGAJSA-N 0.000 description 1
- DEGUERSKQBRZMZ-FXQIFTODSA-N Val-Ser-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DEGUERSKQBRZMZ-FXQIFTODSA-N 0.000 description 1
- MNSSBIHFEUUXNW-RCWTZXSCSA-N Val-Thr-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N MNSSBIHFEUUXNW-RCWTZXSCSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 108010045514 alpha-lactorphin Proteins 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010001271 arginyl-glutamyl-arginine Proteins 0.000 description 1
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 1
- 108010084758 arginyl-tyrosyl-aspartic acid Proteins 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 108010036027 erythrogenin Proteins 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 108010079547 glutamylmethionine Proteins 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 1
- 108010075431 glycyl-alanyl-phenylalanine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010084389 glycyltryptophan Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 125000002887 hydroxy group Chemical class [H]O* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 108010027338 isoleucylcysteine Proteins 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010047926 leucyl-lysyl-tyrosine Proteins 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 108010017391 lysylvaline Proteins 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- -1 methoxy, carboxyl Chemical class 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 108010024607 phenylalanylalanine Proteins 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 108010025826 prolyl-leucyl-arginine Proteins 0.000 description 1
- 108010093296 prolyl-prolyl-alanine Proteins 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 108700004896 tripeptide FEG Proteins 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
- C12Y103/03—Oxidoreductases acting on the CH-CH group of donors (1.3) with oxygen as acceptor (1.3.3)
- C12Y103/03006—Acyl-CoA oxidase (1.3.3.6)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses an acyl coenzyme A oxidase 2 geneRKACOX2The nucleotide sequence is shown as SEQ ID NO. 1, and the amino acid sequence coded by the gene is shown as SEQ ID NO. 2; the gene is derived from Rhodosporidium toruloides (Rhodosporidium kratochvilovae) YM25235, transferring the gene into Rhodosporidium toruloides YM25235, and experimental results show thatRKACOX2Overexpression of a gene leads to a certain increase in the transcription level of this gene in the cellAt the same timeRKACOX2The over-expression of the gene can promote the synthesis of total carotenoid and each component of the carotenoid; the invention improves the microorganism by means of gene engineering, can improve the yield of the microbial carotenoid, and lays a foundation for large-scale commercial production of the carotenoid.
Description
Technical Field
The invention belongs to the field of biotechnology and genetic engineering, and relates to an acyl-CoA oxidase 2 geneRKACOX2And the application thereof; in particular to a method for preparing a compound preparation from a yeast (rhodosporidium toruloides)Rhodosporidiumkratochvilovae) The gene is cloned in YM25235, linked with a vector and transferred into yeast cells, so that the expression level of the gene is increased and the synthesis of carotenoid is finally promoted.
Background
Carotenoids (carotenoids) are a generic name for terpenoids and their derivatives, which are composed of isoprenoids as basic units. To date, humans have found over 600 natural carotenoids in nature; studies have shown that most carotenoids are compounds containing forty carbons, whose main chain is composed of 4 isoprene units, and are divided into two main groups according to the elements constituting the molecular structure: the molecular structure only contains two elements of carbon and hydrogen, such as beta-carotene, lycopene and the like, which are taken as the first class and are called as carotene family; besides two elements, namely carbon and hydrogen, the molecular structure also contains one or more oxygen atoms to form hydroxyl, methoxy, carboxyl, epoxy compounds and the like, and astaxanthin, lutein, zeaxanthin, canthaxanthin and the like are taken as the second class and are called as the lutein family.
Carotenoids have a variety of physiological functions, and it has been demonstrated that carotenoids have functions of preventing cancer, delaying the progression of cancer, regulating cell growth, and resisting oxidation. The carotenoid molecules have a large number of double bonds, which can quench singlet oxygen, clear free radicals, enhance the resistance of human bodies to diseases, promote the connection and communication among cells, reduce the occurrence of chronic diseases and delay aging; however, the human body cannot synthesize carotenoids by itself and can only ingest them by external sources. Therefore, carotenoids are receiving great attention in the fields of medicine, health care, food and the like.
In addition, carotenoids are also widely used as a feed additive. Research shows that a certain amount of carotenoid is added into animal feed, which is beneficial to improving animal body color and feather color and increasing ornamental value; is also beneficial to improving the production performance, the organism immunity, the breeding efficiency and the like of animals, and has certain promotion effect on increasing the economic benefit of the breeding industry.
Common carotenoid production processes include microbial synthesis, plant extraction and chemical synthesis. The plant extraction method has complex process and high production cost. Meanwhile, the development of plant extraction methods is also limited by various factors (regions, climates, transportation conditions and the like), and large-scale production still has great difficulty. The chemical synthesis method has stronger production capacity and lower production cost compared with the plant extraction method. However, because the activity of the synthesized product is low, the product generally has solvent and raw material residues, and the safety problem possibly exists, so the use is limited to a certain extent; the physiological function of the carotenoid synthesized by the chemical synthesis is poorer than that of the natural carotenoid, and the carotenoid is not easy to be absorbed by a human body; the extraction of carotenoid by biological synthesis is the extraction method with the most development potential at present. The carotenoid produced by microbial fermentation only needs a low-cost natural substrate as a carbon source, and has the advantages of simple process, high production efficiency and consistent biological activity with natural plant extracts. In addition, the production of carotenoid by microbial fermentation is not influenced by environmental factors such as regions, climate and the like.
Disclosure of Invention
The invention aims to provide an acyl-CoA oxidase 2 geneRKACOX2The gene is derived from Rhodosporidium toruloides (Rhodosporidium kratochvilovae) YM25235 by separation; the nucleotide sequence of the gene is shown as SEQ ID NO. 1 or a fragment of the nucleotide sequence, or the nucleotide sequence complementary with the SEQ ID NO. 1, the length of the gene sequence is 2220bp (basic group), and the amino acid sequence coded by the gene is polypeptide shown as SEQ ID NO. 2 or a fragment thereof.
Another object of the present invention is to provide an acyl-CoA oxidase 2 geneRKACOX2The recombinant expression vector of (1) is constructed by directly connecting the gene shown in SEQ ID NO. 1 with different expression vectors (plasmids, viruses or carriers); can be constructed by methods well known to those skilled in the artAcyl-coa containing oxidase 2 geneRKACOX2And suitable transcription/translation regulatory elements. These methods include in vitro recombinant DNA techniques, DNA synthesis techniques, in vivo recombinant techniques, and the like. The acyl-CoA oxidase 2 geneRKACOX2Can be operably linked to an appropriate promoter of an expression vector to direct mRNA synthesis. Representative examples of such promoters are: lac or trp promoter of E.coli; the PL promoter of lambda phage; eukaryotic promoters include CMV early promoter, HSV thymidine kinase promoter, early and late SV40 promoter, LTRs of retrovirus, and other known promoters capable of controlling the expression of genes in prokaryotic or eukaryotic cells or viruses. The expression vector also includes a ribosome binding site for translation initiation, a transcription terminator, and the like. The insertion of enhancer sequences into vectors will enhance transcription in higher eukaryotic cells. Enhancers are cis-acting elements of DNA expression, usually about 10-300bp, that act on a promoter to enhance gene transcription, such as adenovirus enhancers.
Another object of the present invention is to provide an acyl-CoA oxidase 2 geneRKACOX2Or a host cell of the above recombinant expression vector.
Another object of the present invention is to provide the above-mentioned acyl-CoA oxidase 2 geneRKACOX2Application to the promotion of microbial production of carotenoids.
The acyl-CoA oxidase 2 geneRKACOX2Is red winter spore yeast (Rhodosporidium kratochvilovae) The important gene in the YM25235 fatty acid metabolic process and the coded enzyme are responsible for the degradation of branched-chain fatty acid, can regulate and control the fatty acid metabolism and further influence the rhodosporidium toruloides (R) ((R))Rhodosporidium kratochvilovae) Synthesis of carotenoids from YM25235 strain.
The Rhodosporidium toruloides (A), (B) and (C)Rhodosporidium kratochvilovae) YM25235 has the advantages of short production cycle, stable heredity, safe production, etc.
The invention relates to a method for preparing a red wintergreen spore yeast (Rhodosporidium toruloides)Rhodosporidium kratochvilovae) acyl-CoA oxidase 2 group isolated from YM25235 Total RNA GeneDue to the fact thatRKACOX2The total length of the gene is 2220 bp; the gene is transferred into Rhodosporidium toruloides YM25235, and the experimental result shows thatRKACOX2The overexpression of the gene can cause the transcription level of the gene in the cell to be improved to a certain extent, which indicates that the exogenous gene is transcribed in the thalli;RKACOX2the over-expression of the gene can promote the synthesis of total carotenoid and each component of the carotenoid; the research result provides reference for disclosing a mechanism of increasing the yield of the carotenoid by the microorganism, is beneficial to improving the carotenoid content by modifying the microorganism by a genetic engineering means, has good application prospect and economic benefit for industrial production of the carotenoid, and lays a foundation for large-scale commercial production of the carotenoid.
Drawings
FIG. 1 shows a scheme for producing Rhodosporidium toruloides YM25235 of the present inventionRKACOX2A gene PCR amplification map;
FIG. 2 is a plasmid map of recombinant plasmid pRHRKACOX 2;
FIG. 3 shows the PCR identification of YM25235 strain transformed with recombinant plasmid pRHRKACOX2, FIG. 1. DNA molecular scalar DL 5000; 2. PCR products with primers RKACOX2-F and RKACOX2-R using YM25235 genome as template; 3. PCR products of primers RKACOX2-F and RKACOX2-R with plasmid pRHRKACOX2 as template; 4. PCR products of primers RKACOX2-F and RKACOX2-R with YM25235/pRHRKACOX2 strain genome as template;
FIG. 4 shows a comparison of the total carotenoid content of the over-expressed strain YM25235/pRHRKACOX2 with the control strain YM25235/pRH 2034;
FIG. 5 shows the comparison of the carotenoid content of each component in the overexpressed strain YM25235/pRHRKACOX2 with that of the control strain YM25235/pRH 2034;
FIG. 6 is a relative quantitative analysis of carotenoid synthesis related genes of overexpression strain YM25235/pRHRKACOX2 and control strain YM25235/pRH 2034.
Detailed Description
The present invention is further illustrated in detail below with reference to the drawings and examples, but the scope of the present invention is not limited to the above description, and reagents and methods used in the examples are, unless otherwise specified, conventional reagents and conventional methods.
Example 1: from Rhodosporidium toruloides (A)Rhodosporidium kratochvilovae) Isolation of acyl-CoA oxidase 2 Gene from YM25235RKACOX2The nucleotide sequence of (A) and the construction of an overexpression vector pRHRKACOX2 thereof
Extracting total RNA of Rhodosporidium toruloides YM25235 by using UNlQ-10 column type Trizol total RNA extraction Kit (product number: SK 1321) of bio-engineering (Shanghai) Co., Ltd, performing reverse transcription according to PrimeScript RT reagent Kit With gDNA Eraser (Perfect Real Time) of TaKaRa Co., Ltd to synthesize cDNA, performing polymerase chain reaction by using 0.5 mu L as a template, and sequencing according to the transcription setRKACOX2Designing specific primers RKACOX2-F and RKACOX2-R (primer 1 and primer 2), carrying out PCR amplification on the cDNA template obtained in the way on a PCR instrument (BIOER company), wherein the primers, components and amplification conditions used in the reaction are as follows:
RKACOX2-R:
amplification conditions: pre-denaturing at 95 ℃ for 5 min, further denaturing at 95 ℃ for 30s, annealing at 62 ℃ for 30s, extending at 72 ℃ for 2min for 30s, performing 30 cycles, finally completely extending at 72 ℃ for 10min, taking 2. mu.L of the product after the reaction, performing electrophoresis analysis in 1% agarose gel to obtain a fragment of about 2200bp, recovering the fragment by ethanol precipitation, and using a seamless Cloning Kit (Vazyme Clon express II One Step Cloning Kit, Nanjing Nuo Tou Zan Biotech Limited public Key)And) connecting the recovered fragment to a vector pRH2034 to obtain a recombinant vector; transformation of the recombinant vector into the vector with CaCl2Carrying out overnight culture on Escherichia coli DH5 alpha treated by the method on an LB solid plate containing spectinomycin (100 mug/mL), selecting a white colony growing on the plate, and verifying positive clones by colony PCR; inoculating positive clones into LB liquid culture medium (containing 100 mug/mL spectinomycin) for overnight culture, extracting plasmids (OMEGA Plasmid Mini Kit I, American OMEGA company) for sequencing (Kunming engine science and technology, Inc.), wherein the result shows that the size of the amplified fragment is 2220bp, which is named as RKACOX2, and the sequence composition is a nucleotide sequence shown as SEQ ID NO: 1; the recombinant vector was pRHRKACOX2 (FIG. 2).
Example 2: analysis of the relationship between RKACOX2 gene and carotenoid synthesis in Rhodosporidium toruloides
1. Transformed Rhodosporidium toruloides YM25235
The recombinant vector pRHRKACOX2 is transformed into Rhodosporidium toruloides YM25235 by a PEG-mediated protoplast method, transformants are screened by a YPD culture medium containing hygromycin B (hygromycin B) with the final concentration of 150 mug/mL, then genomic DNA of the yeast transformants is extracted according to the steps in the DNA extraction kit specification of Shanghai biological engineering Co., Ltd, and then PCR verification is carried out, wherein the result is shown in FIG. 3.
2. Analysis of changes in the content of RKACOX2 Gene and Total carotenoids in Rhodosporidium toruloides
Culturing overexpression strain containing pRHRKACOX2 at 28 deg.C, extracting carotenoid, and determining total carotenoid content (mg/g dry thallus) at 445nm with ultraviolet-visible spectrophotometer using Rhodosporidium toruloides strain transferred to empty plasmid pRH2034 as control, the result is shown in FIG. 4; as can be seen from the graphs, the total carotenoid synthesis of the overexpressed strain YM25235/pRHRKACOX2 was significantly improved as compared with the control strain containing the empty plasmid pRH2034, the carotenoid synthesis of the control strain containing the empty plasmid pRH2034 was 5.68mg/g, and the carotenoid synthesis of the overexpressed strain YM25235/pRHRKACOX2 was 7.59mg/g, i.e., the carotenoid synthesis of the overexpressed strain YM25235/pRHRKACOX2 was 1.34 times that of the control strain, indicating that RKACOX2 gene was able to promote the synthesis of total carotenoids.
3. Analysis of content variation of components of RKACOX2 gene and rhodosporidium toruloides carotenoid
After culturing the overexpression strain containing pRHRKACOX2 at 28 ℃ for 168h, extracting carotenoid, and performing high performance liquid chromatography analysis by using original Rhodosporidium toruloides YM25235 strain as a control, the result is shown in FIG. 5, and it can be seen from the figure that the content of each component of carotenoid of the overexpression strain YM25235/pRHRKACOX2 is improved to different degrees compared with the original strain; wherein, the content of the over-expression strain YM25235/pRHRKACOX2 rhodotorula rubra erythrogenin (torularhodin) is increased by 6.5 percent, the content of beta-carotene (beta-carotene) is increased by 60.7 percent, the content of the round yeast extract (torulone) is increased by 164.6 percent, and the content of gamma-carotene (gamma-carotene) is increased by 176.4 percent; the results show thatRKACOX2The gene can promote the synthesis of each component of carotenoid.
Example 3: analysis of relationship between RKACOX2 gene and carotenoid synthesis related gene in Rhodosporidium toruloides
Culturing the transgenic strain YM25235/pRHRKACOX2 and the control strain YM25235/pRH2304 on a constant temperature shaker at 30 ℃ and 220rpm for 120h by shaking, extracting total RNA of Rhodosporidium toruloides YM25235 by using UNlQ-10 column type Trizol total RNA extraction Kit (product number: SK 1321) of Shanghai bioengineering (Shanghai) Co., Ltd, performing reverse transcription according to PrimeScript RT reagent Kit With gDNA Eraser (Perfect Time) of TaKaRa Co., synthesizing related genes by the reverse transcription of the transgenic strain YM 25235/pRKAHRCOX 2 and the control strain YM25235/pRH2304 carotenoidRkCrtI、RkCrtYBIs analyzed for the transcript level of (2). 5.8S rRNA of Rhodosporidium toruloides YM25235 is used as an internal reference gene, and carotenoid is used for synthesizing related genesRkCrtI、RkCrtYBThe transcription level of the corresponding gene of the control strain YM25235/pRH2304 is used as a control, and the 2-delta-Delta CT value is 1; the relative quantitative (Bestar SybrGreen qPCR MasterMix kit, DBI, Germany) analysis results are shown in FIG. 6, which shows that the transgenic strain YM25235/pRHRKACOX2RKCrtYBTransformation of genesThe recording level is the control strain YM25235/pRH2304RKCrtYB1.9 times the level of gene transcription. Transgenic strain YM25235/pRHRKACOX2RKCrtIThe transcription level of the gene was that of the control strain YM25235/pRH2304RKCrtI10.1 fold higher gene transcript levels. These results indicate that overexpression of RKACOX2 gene in Rhodosporidium toruloides YM25235 results in an increase in the transcription level of mRNA of genes involved in carotenoid synthesis in cells.
Sequence listing
<110> university of Kunming science
<120> acyl-CoA oxidase 2 gene RKACOX2 and application thereof
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 2220
<212> DNA
<213> Rhodosporidium toruloides YM25235(Rhodosporidium kratochvilovae YM25235)
<400> 1
atgccgacgc ccgtcgatgc ccagccccgc ccgccagccc cgcgcgagac gatggccgca 60
gagcgtgcga gcgcagaggg cgcgttcgac ctcgagcgga tgtgcaacgc catgggcgga 120
ggcgagtaca acgtcaagct gaagcgcaag ttcatgttcg agctcgagcg cgacccgctc 180
ttcaagctct ccgacattca cgacctcacc aaggccgaga ttcgcgagcg gaccatggcc 240
aagtttgcgt cgatggtcca ctacgtcacg aacgagccta tcgcccagtt ccagcagcgc 300
atgaacgtcg tttctaccgc cgacccggct ttctggacgc gatatggagt gcactatggc 360
ctgttcctcg gcgcgctccg ctctggcgca acgcccaacc agatgagcta ctggatgtcg 420
cgcggcgtca tcaccctgca gggcatggtc ggctgcttcg cgatgactga gctcgctcac 480
ggttcgaacg tcgcgggcct cgagacgacc gcaaccttcg acgagacggc ggaccagttc 540
gtcatccaca cgccgtccgt ctcggcgacc aagtggtgga tcggcggcgc ggcgcactcg 600
gcgacgcaca gcgccgtctt tgcccgcctt atcgtcaagg ggatggacta cgggaccaag 660
acgttcgtcg tcccgcttcg caaccccaag acgtacgagc tcctgcccgg catcgcaatc 720
ggcgacattg gcaagaagat ggggcgcgac ggcatcgaca acggctggat ccagttcacc 780
aacgtccgca tcccgcgcgc atacatgctc atgaagcaca ccaaggtgac gcgcgagggc 840
gaggtgcgcg agccgccgct cgcgcagctg acatacggcg cgctgctgca aggccgcacg 900
gcgatggtcg ccgacgcggc gtcgacggcg aagaaggcgc tgacgatcgc gctccggtac 960
gcggcggtgc ggcggcagtt caagacgggc gacaacgcgc tcgagacgca gctcctcgac 1020
tacccgatcc accagcgccg gctgctcccc ctcctcgcgc aggccgtcgc gatgggtttc 1080
acgtcgttcc gcatgacggc gctcttcgag gagatgagcg aggagctcga gtcgctcggg 1140
agcgactcgg acgccgacga gaccaagtcg gtcctcgaga agctcaagga gacgcacgcg 1200
acgagcgcag gcctcaaggc cttctgcacg tggaacgcgc tcgagacgat cgagaagtgc 1260
cgtgcgagcc tcggtgggca cggctactcg gcgtactcgg cgctgccgag catgtacaac 1320
gaccaggccg tccagtgcac ctgggagggc gacaacacga tcctcacgct ccagtcgggt 1380
cgctcgctcg tctcgtccta cgccgacgcg gtcaagggcg cgaagctccc gggcgggacg 1440
gcgtacctca acgcgctccc ctccgtgctc acgacgtcct gcccgtcgga cgcggcgacg 1500
ctcgagctcg acacgctcca ggccgcgtgg gactgcgtct cggcgaacgt ggtcaagcag 1560
gcgcacgaca agttcgaggg cgcgctcaag agcggcgagg ccaagggccg cgaggaggcg 1620
ctcgagatgt gctcgcagga gcggttcatc gccgccaagg tgcacactgc cggctacctc 1680
ttccgcatgt tccgcgaggc gctcgtcgag ctcgccaaga ctgagccggc ggacaacggc 1740
gtcgtcgcga cgctggagca gatctgcacg ctgtacgggt gctgggcgat cgaggagaac 1800
gcgcagcact tcctcaagta ccggttcttc accccgagcc agatggacgc catcacggcc 1860
gaggtgacgc gcctgtgcgc cgtcctccgc aagtctgcgg tgctcctcac cgatagcttt 1920
gacctctcgg accacatcat caactcgccg ctcggacggt acgacggcga catctacaac 1980
cactactttg cgcacgtcaa ggccgcgaac ccgcacgagc cggtcgcgcc gtactttgcg 2040
cgggtgatca agccgctgat tgagcgcgag gacctctcgt tcgacgacgc ggacgagatc 2100
gacctcgatg ccgagctgca ggagctcgag gaggaggagg cggacgacga agaggtcgag 2160
gacgaggcgg acaagacggc gcaggccgag aaggaactcg agaagccggc gaaggagtag 2220
<210> 2
<211> 739
<212> PRT
<213> Rhodosporidium toruloides YM25235(Rhodosporidium kratochvilovae YM25235)
<400> 2
Met Pro Thr Pro Val Asp Ala Gln Pro Arg Pro Pro Ala Pro Arg Glu
1 5 10 15
Thr Met Ala Ala Glu Arg Ala Ser Ala Glu Gly Ala Phe Asp Leu Glu
20 25 30
Arg Met Cys Asn Ala Met Gly Gly Gly Glu Tyr Asn Val Lys Leu Lys
35 40 45
Arg Lys Phe Met Phe Glu Leu Glu Arg Asp Pro Leu Phe Lys Leu Ser
50 55 60
Asp Ile His Asp Leu Thr Lys Ala Glu Ile Arg Glu Arg Thr Met Ala
65 70 75 80
Lys Phe Ala Ser Met Val His Tyr Val Thr Asn Glu Pro Ile Ala Gln
85 90 95
Phe Gln Gln Arg Met Asn Val Val Ser Thr Ala Asp Pro Ala Phe Trp
100 105 110
Thr Arg Tyr Gly Val His Tyr Gly Leu Phe Leu Gly Ala Leu Arg Ser
115 120 125
Gly Ala Thr Pro Asn Gln Met Ser Tyr Trp Met Ser Arg Gly Val Ile
130 135 140
Thr Leu Gln Gly Met Val Gly Cys Phe Ala Met Thr Glu Leu Ala His
145 150 155 160
Gly Ser Asn Val Ala Gly Leu Glu Thr Thr Ala Thr Phe Asp Glu Thr
165 170 175
Ala Asp Gln Phe Val Ile His Thr Pro Ser Val Ser Ala Thr Lys Trp
180 185 190
Trp Ile Gly Gly Ala Ala His Ser Ala Thr His Ser Ala Val Phe Ala
195 200 205
Arg Leu Ile Val Lys Gly Met Asp Tyr Gly Thr Lys Thr Phe Val Val
210 215 220
Pro Leu Arg Asn Pro Lys Thr Tyr Glu Leu Leu Pro Gly Ile Ala Ile
225 230 235 240
Gly Asp Ile Gly Lys Lys Met Gly Arg Asp Gly Ile Asp Asn Gly Trp
245 250 255
Ile Gln Phe Thr Asn Val Arg Ile Pro Arg Ala Tyr Met Leu Met Lys
260 265 270
His Thr Lys Val Thr Arg Glu Gly Glu Val Arg Glu Pro Pro Leu Ala
275 280 285
Gln Leu Thr Tyr Gly Ala Leu Leu Gln Gly Arg Thr Ala Met Val Ala
290 295 300
Asp Ala Ala Ser Thr Ala Lys Lys Ala Leu Thr Ile Ala Leu Arg Tyr
305 310 315 320
Ala Ala Val Arg Arg Gln Phe Lys Thr Gly Asp Asn Ala Leu Glu Thr
325 330 335
Gln Leu Leu Asp Tyr Pro Ile His Gln Arg Arg Leu Leu Pro Leu Leu
340 345 350
Ala Gln Ala Val Ala Met Gly Phe Thr Ser Phe Arg Met Thr Ala Leu
355 360 365
Phe Glu Glu Met Ser Glu Glu Leu Glu Ser Leu Gly Ser Asp Ser Asp
370 375 380
Ala Asp Glu Thr Lys Ser Val Leu Glu Lys Leu Lys Glu Thr His Ala
385 390 395 400
Thr Ser Ala Gly Leu Lys Ala Phe Cys Thr Trp Asn Ala Leu Glu Thr
405 410 415
Ile Glu Lys Cys Arg Ala Ser Leu Gly Gly His Gly Tyr Ser Ala Tyr
420 425 430
Ser Ala Leu Pro Ser Met Tyr Asn Asp Gln Ala Val Gln Cys Thr Trp
435 440 445
Glu Gly Asp Asn Thr Ile Leu Thr Leu Gln Ser Gly Arg Ser Leu Val
450 455 460
Ser Ser Tyr Ala Asp Ala Val Lys Gly Ala Lys Leu Pro Gly Gly Thr
465 470 475 480
Ala Tyr Leu Asn Ala Leu Pro Ser Val Leu Thr Thr Ser Cys Pro Ser
485 490 495
Asp Ala Ala Thr Leu Glu Leu Asp Thr Leu Gln Ala Ala Trp Asp Cys
500 505 510
Val Ser Ala Asn Val Val Lys Gln Ala His Asp Lys Phe Glu Gly Ala
515 520 525
Leu Lys Ser Gly Glu Ala Lys Gly Arg Glu Glu Ala Leu Glu Met Cys
530 535 540
Ser Gln Glu Arg Phe Ile Ala Ala Lys Val His Thr Ala Gly Tyr Leu
545 550 555 560
Phe Arg Met Phe Arg Glu Ala Leu Val Glu Leu Ala Lys Thr Glu Pro
565 570 575
Ala Asp Asn Gly Val Val Ala Thr Leu Glu Gln Ile Cys Thr Leu Tyr
580 585 590
Gly Cys Trp Ala Ile Glu Glu Asn Ala Gln His Phe Leu Lys Tyr Arg
595 600 605
Phe Phe Thr Pro Ser Gln Met Asp Ala Ile Thr Ala Glu Val Thr Arg
610 615 620
Leu Cys Ala Val Leu Arg Lys Ser Ala Val Leu Leu Thr Asp Ser Phe
625 630 635 640
Asp Leu Ser Asp His Ile Ile Asn Ser Pro Leu Gly Arg Tyr Asp Gly
645 650 655
Asp Ile Tyr Asn His Tyr Phe Ala His Val Lys Ala Ala Asn Pro His
660 665 670
Glu Pro Val Ala Pro Tyr Phe Ala Arg Val Ile Lys Pro Leu Ile Glu
675 680 685
Arg Glu Asp Leu Ser Phe Asp Asp Ala Asp Glu Ile Asp Leu Asp Ala
690 695 700
Glu Leu Gln Glu Leu Glu Glu Glu Glu Ala Asp Asp Glu Glu Val Glu
705 710 715 720
Asp Glu Ala Asp Lys Thr Ala Gln Ala Glu Lys Glu Leu Glu Lys Pro
725 730 735
Ala Lys Glu
<210> 3
<211> 40
<212> DNA
<213> Artificial sequence (Artificial)
<400> 3
accagatcac tcaccatggc gatgccgacg cccgtcgatg 40
<210> 4
<211> 39
<212> DNA
<213> Artificial sequence (Artificial)
<400> 4
ccggtcggca tctacgatat cctactcctt cgccggctt 39
Claims (2)
1. acyl-CoA oxidase 2 geneRKACOX2The nucleotide sequence is shown as SEQ ID NO. 1, and the amino acid sequence coded by the gene is shown as SEQ ID NO. 2.
2. The acyl-CoA oxidase 2 gene according to claim 1RKACOX2Application in promoting microbial production of carotenoid is provided.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011322537.1A CN112410355B (en) | 2020-11-23 | 2020-11-23 | Acyl-coenzyme A oxidase 2 gene RKACOX2 and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011322537.1A CN112410355B (en) | 2020-11-23 | 2020-11-23 | Acyl-coenzyme A oxidase 2 gene RKACOX2 and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112410355A true CN112410355A (en) | 2021-02-26 |
CN112410355B CN112410355B (en) | 2022-03-25 |
Family
ID=74777416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011322537.1A Active CN112410355B (en) | 2020-11-23 | 2020-11-23 | Acyl-coenzyme A oxidase 2 gene RKACOX2 and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112410355B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108624600A (en) * | 2018-05-22 | 2018-10-09 | 昆明理工大学 | The purposes of zinc finger transcriptional factor genes RkMsn4 |
CN110747206A (en) * | 2019-11-05 | 2020-02-04 | 昆明理工大学 | 3-hydroxy-3-methylglutaryl coenzyme A reductase gene RKHMGR and application thereof |
CN113621630A (en) * | 2021-08-05 | 2021-11-09 | 昆明理工大学 | 3-ketoacyl-CoA thiolase gene RkACAA1-1 and application thereof |
CN113652440A (en) * | 2021-08-05 | 2021-11-16 | 昆明理工大学 | 3-ketoacyl-coenzyme A thiolase gene RKACAA1-2 and application thereof |
CN114107340A (en) * | 2021-08-11 | 2022-03-01 | 昆明理工大学 | Mevalonate kinase gene RKMK and application thereof |
CN114540356A (en) * | 2022-02-25 | 2022-05-27 | 昆明理工大学 | Rhodosporidium toruloides promoter and application thereof |
CN115011616A (en) * | 2022-01-26 | 2022-09-06 | 昆明理工大学 | Acetaldehyde dehydrogenase gene RKALDH and application thereof |
Citations (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020182600A1 (en) * | 2001-04-11 | 2002-12-05 | Smith Jack V. | Method for assaying biological and other constituents using synthetic nucleounits in lateral flow, liquid, and dry chemistry techniques |
CN101448946A (en) * | 2006-05-17 | 2009-06-03 | 纳幕尔杜邦公司 | Delta-5 desaturase from peridinium sp. and its use in making polyunsaturated fatty acids |
EP2294193A2 (en) * | 2008-04-10 | 2011-03-16 | DSM IP Assets B.V. | Production of carotenoids in oleaginous yeast and fungi |
CN103648499A (en) * | 2011-01-10 | 2014-03-19 | 无限药品股份有限公司 | Processes for preparing isoquinolinones and solid forms of isoquinolinones |
CN104946668A (en) * | 2015-06-29 | 2015-09-30 | 湖南省植物保护研究所 | cry1Ia gene and application thereof, Cry1Ia protein coded by cry1Ia gene, and preparation method and application thereof |
WO2017108577A1 (en) * | 2015-12-21 | 2017-06-29 | Carbios | Recombinant yeast cells producing polylactic acid and uses thereof |
CN108473993A (en) * | 2015-10-27 | 2018-08-31 | 韩国生命工学研究院 | The production method of middle chain amino carboxylic acid |
CN109666683A (en) * | 2019-02-27 | 2019-04-23 | 昆明理工大学 | Acetyl coenzyme A acetyl transferase gene RKAcaT2 and its application |
CN110268058A (en) * | 2017-02-27 | 2019-09-20 | 积水化学工业株式会社 | The production method of recombinant cell, the preparation method of recombinant cell and isoprene or terpenes |
CN110747206A (en) * | 2019-11-05 | 2020-02-04 | 昆明理工大学 | 3-hydroxy-3-methylglutaryl coenzyme A reductase gene RKHMGR and application thereof |
US10648043B2 (en) * | 2016-03-04 | 2020-05-12 | Total Raffinage Chimie | Method of producing fatty acids |
US10648020B2 (en) * | 2015-06-18 | 2020-05-12 | The Broad Institute, Inc. | CRISPR enzymes and systems |
US10662448B2 (en) * | 2016-10-17 | 2020-05-26 | Xylome Corporation | Compositions and methods for producing lipids and other biomaterials from grain ethanol stillage and stillage derivatives |
US10669540B2 (en) * | 2015-06-18 | 2020-06-02 | The Board Institute, Inc. | CRISPR enzymes and systems |
US10696460B2 (en) * | 2012-04-16 | 2020-06-30 | Monosol, Llc | Powdered pouch and method of making same |
CN111394400A (en) * | 2019-01-03 | 2020-07-10 | 上海凯赛生物技术股份有限公司 | Application of SCT1 gene in production of long-chain dicarboxylic acid |
CN111394399A (en) * | 2019-01-03 | 2020-07-10 | 上海凯赛生物技术股份有限公司 | Method for reducing content of acylglyceride impurities in long-chain dibasic acid |
US10724041B2 (en) * | 2014-05-29 | 2020-07-28 | Novogy, Inc. | Increasing lipid production and optimizing lipid composition |
CN111454854A (en) * | 2020-05-02 | 2020-07-28 | 昆明理工大学 | Rhodosporidium toruloides gene engineering strain for producing astaxanthin |
US10750711B2 (en) * | 2015-06-08 | 2020-08-25 | Indigo Ag, Inc. | Streptomyces endophyte compositions and methods for improved agronomic traits in plants |
WO2020169389A1 (en) * | 2019-02-19 | 2020-08-27 | Biophero Aps | Methods and cell factories for producing insect pheromones |
WO2021078452A1 (en) * | 2019-10-22 | 2021-04-29 | Biophero Aps | Improved methods for production, recovery and secretion of hydrophobic compounds in a fermentation |
CN112739365A (en) * | 2018-08-10 | 2021-04-30 | 糖平制药公司 | Tripeptides and treatment of metabolic, cardiovascular and inflammatory disorders |
CN112831427A (en) * | 2021-01-20 | 2021-05-25 | 山东大学 | Yarrowia lipolytica for high yield of beta-carotene and application thereof |
WO2021123128A1 (en) * | 2019-12-20 | 2021-06-24 | Biophero Aps | Yeast cells and methods for production of e8,e10-dodecadienyl coenzyme a, codlemone and derivatives thereof |
CN113430215A (en) * | 2021-06-03 | 2021-09-24 | 昆明理工大学 | Acetyl CoA synthetase gene RKACS1 and application thereof |
-
2020
- 2020-11-23 CN CN202011322537.1A patent/CN112410355B/en active Active
Patent Citations (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020182600A1 (en) * | 2001-04-11 | 2002-12-05 | Smith Jack V. | Method for assaying biological and other constituents using synthetic nucleounits in lateral flow, liquid, and dry chemistry techniques |
CN101448946A (en) * | 2006-05-17 | 2009-06-03 | 纳幕尔杜邦公司 | Delta-5 desaturase from peridinium sp. and its use in making polyunsaturated fatty acids |
EP2294193A2 (en) * | 2008-04-10 | 2011-03-16 | DSM IP Assets B.V. | Production of carotenoids in oleaginous yeast and fungi |
CN103648499A (en) * | 2011-01-10 | 2014-03-19 | 无限药品股份有限公司 | Processes for preparing isoquinolinones and solid forms of isoquinolinones |
US10696460B2 (en) * | 2012-04-16 | 2020-06-30 | Monosol, Llc | Powdered pouch and method of making same |
US10724041B2 (en) * | 2014-05-29 | 2020-07-28 | Novogy, Inc. | Increasing lipid production and optimizing lipid composition |
US10750711B2 (en) * | 2015-06-08 | 2020-08-25 | Indigo Ag, Inc. | Streptomyces endophyte compositions and methods for improved agronomic traits in plants |
US10669540B2 (en) * | 2015-06-18 | 2020-06-02 | The Board Institute, Inc. | CRISPR enzymes and systems |
US10648020B2 (en) * | 2015-06-18 | 2020-05-12 | The Broad Institute, Inc. | CRISPR enzymes and systems |
CN104946668A (en) * | 2015-06-29 | 2015-09-30 | 湖南省植物保护研究所 | cry1Ia gene and application thereof, Cry1Ia protein coded by cry1Ia gene, and preparation method and application thereof |
CN108473993A (en) * | 2015-10-27 | 2018-08-31 | 韩国生命工学研究院 | The production method of middle chain amino carboxylic acid |
WO2017108577A1 (en) * | 2015-12-21 | 2017-06-29 | Carbios | Recombinant yeast cells producing polylactic acid and uses thereof |
US10648043B2 (en) * | 2016-03-04 | 2020-05-12 | Total Raffinage Chimie | Method of producing fatty acids |
US10662448B2 (en) * | 2016-10-17 | 2020-05-26 | Xylome Corporation | Compositions and methods for producing lipids and other biomaterials from grain ethanol stillage and stillage derivatives |
CN110268058A (en) * | 2017-02-27 | 2019-09-20 | 积水化学工业株式会社 | The production method of recombinant cell, the preparation method of recombinant cell and isoprene or terpenes |
CN112739365A (en) * | 2018-08-10 | 2021-04-30 | 糖平制药公司 | Tripeptides and treatment of metabolic, cardiovascular and inflammatory disorders |
CN111394400A (en) * | 2019-01-03 | 2020-07-10 | 上海凯赛生物技术股份有限公司 | Application of SCT1 gene in production of long-chain dicarboxylic acid |
CN111394399A (en) * | 2019-01-03 | 2020-07-10 | 上海凯赛生物技术股份有限公司 | Method for reducing content of acylglyceride impurities in long-chain dibasic acid |
WO2020169389A1 (en) * | 2019-02-19 | 2020-08-27 | Biophero Aps | Methods and cell factories for producing insect pheromones |
CN109666683A (en) * | 2019-02-27 | 2019-04-23 | 昆明理工大学 | Acetyl coenzyme A acetyl transferase gene RKAcaT2 and its application |
WO2021078452A1 (en) * | 2019-10-22 | 2021-04-29 | Biophero Aps | Improved methods for production, recovery and secretion of hydrophobic compounds in a fermentation |
CN110747206A (en) * | 2019-11-05 | 2020-02-04 | 昆明理工大学 | 3-hydroxy-3-methylglutaryl coenzyme A reductase gene RKHMGR and application thereof |
WO2021123128A1 (en) * | 2019-12-20 | 2021-06-24 | Biophero Aps | Yeast cells and methods for production of e8,e10-dodecadienyl coenzyme a, codlemone and derivatives thereof |
CN111454854A (en) * | 2020-05-02 | 2020-07-28 | 昆明理工大学 | Rhodosporidium toruloides gene engineering strain for producing astaxanthin |
CN112831427A (en) * | 2021-01-20 | 2021-05-25 | 山东大学 | Yarrowia lipolytica for high yield of beta-carotene and application thereof |
CN113430215A (en) * | 2021-06-03 | 2021-09-24 | 昆明理工大学 | Acetyl CoA synthetase gene RKACS1 and application thereof |
Non-Patent Citations (5)
Title |
---|
FAKANKUN,I.U.等: ""acyl-CoA dehydrogenase/oxidase C-terminal [Rhodotorula diobovata]"", 《GENBANK DATABASE》 * |
FIRRINCIELI,A.等: ""Rhodotorula graminis WP1 uncharacterized protein (RHOBADRAFT_55802), partial mRNA"", 《GENBANK DATABASE》 * |
XIN-KAI ZHANG等: ""Metabolic engineering of b-carotene biosynthesis in Yarrowia lipolytica"", 《BIOTECHNOL LETT》 * |
和美霞等: ""过表达RkHMGCR基因对红冬孢酵母类胡萝卜素合成的影响"", 《云南大学学报( 自然科学版)》 * |
尹升明: ""代谢工程改造耶罗维解脂酵母生产β-胡萝卜素研究"", 《中国优秀博硕士学位论文全文数据库(博士)工程科技Ⅰ辑》 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108624600A (en) * | 2018-05-22 | 2018-10-09 | 昆明理工大学 | The purposes of zinc finger transcriptional factor genes RkMsn4 |
CN110747206A (en) * | 2019-11-05 | 2020-02-04 | 昆明理工大学 | 3-hydroxy-3-methylglutaryl coenzyme A reductase gene RKHMGR and application thereof |
CN110747206B (en) * | 2019-11-05 | 2021-11-23 | 昆明理工大学 | 3-hydroxy-3-methylglutaryl coenzyme A reductase gene RKHMGR and application thereof |
CN113621630A (en) * | 2021-08-05 | 2021-11-09 | 昆明理工大学 | 3-ketoacyl-CoA thiolase gene RkACAA1-1 and application thereof |
CN113652440A (en) * | 2021-08-05 | 2021-11-16 | 昆明理工大学 | 3-ketoacyl-coenzyme A thiolase gene RKACAA1-2 and application thereof |
CN113621630B (en) * | 2021-08-05 | 2023-03-24 | 昆明理工大学 | 3-ketoacyl-CoA thiolase gene RkACAA1-1 and application thereof |
CN113652440B (en) * | 2021-08-05 | 2023-04-21 | 昆明理工大学 | 3-ketoacyl coenzyme A thiolase gene RKACAA1-2 and application thereof |
CN114107340A (en) * | 2021-08-11 | 2022-03-01 | 昆明理工大学 | Mevalonate kinase gene RKMK and application thereof |
CN115011616A (en) * | 2022-01-26 | 2022-09-06 | 昆明理工大学 | Acetaldehyde dehydrogenase gene RKALDH and application thereof |
CN114540356A (en) * | 2022-02-25 | 2022-05-27 | 昆明理工大学 | Rhodosporidium toruloides promoter and application thereof |
CN114540356B (en) * | 2022-02-25 | 2023-09-01 | 昆明理工大学 | Rhodosporidium toruloides promoter and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN112410355B (en) | 2022-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112410355B (en) | Acyl-coenzyme A oxidase 2 gene RKACOX2 and application thereof | |
CN109666683B (en) | Acetyl coenzyme A acetyltransferase gene RKAcaT2 and application thereof | |
CN109777815B (en) | HMG-CoA synthetase gene RKHMGCS and application thereof | |
CN110747206B (en) | 3-hydroxy-3-methylglutaryl coenzyme A reductase gene RKHMGR and application thereof | |
CN113430215B (en) | Acetyl CoA synthetase gene RKACS1 and application thereof | |
KR102202606B1 (en) | A microorganism for producing a bio-retinol and a method for preparing a bio-retinol using the same | |
CN111454854B (en) | Rhodosporidium toruloides gene engineering strain for producing astaxanthin | |
CN110106206B (en) | Corynebacterium glutamicum construction method for improving yield and stability of L-lysine | |
CN108456666B (en) | 3-sterone-delta1Dehydrogenase and coding gene and application thereof | |
CN115011616B (en) | Acetaldehyde dehydrogenase gene RKALDH and application thereof | |
CN109536518A (en) | A kind of Phytoene dehydrogenase gene RKcrtI and its application | |
CN115851779B (en) | Glucose-6-phosphate dehydrogenase gene RkZWF1 and application thereof | |
CN116286900A (en) | Acetate osmotic enzyme A gene RkAcpa and application thereof | |
CN107287222B (en) | Application of Hisk2301 gene of histidine kinase | |
CN110938606B (en) | HpaBC gene, mutant and application thereof | |
CN116286880B (en) | Peroxisome increment factor gene RkPEX and application thereof | |
CN106754979B (en) | Gene for regulating and controlling long-chain fatty acid transport of candida tropicalis and application of gene | |
CN111454918B (en) | Enol reductase mutant and application thereof in preparation of (R) -citronellal | |
JP7072809B2 (en) | Use in the production of recombinant microorganisms, their production methods and coenzyme Q10 | |
CN112574898A (en) | Recombinant yeast for producing lutein and application thereof | |
CN108624600B (en) | Application of zinc finger transcription factor gene RkMsn4 | |
CN112608936A (en) | Promoter for regulating and controlling expression of yeast exogenous gene, regulation and control method and application thereof | |
CN104278015B (en) | One plant height effect is overexpressed the phaffia rhodozyma bacterial strain of endogenous chemical activators enzyme gene | |
CN113736806B (en) | Gene for improving oil synthesis of marine nannochloropsis and application thereof | |
CN109609519A (en) | A kind of gene RKcrtYB and its application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |